Europe Synthetic Biology Market Size & Outlook, 2023-2030
Europe synthetic biology market, 2018-2030 (US$M)
Related Markets
Europe synthetic biology market highlights
- The Europe synthetic biology market generated a revenue of USD 4,245.1 million in 2023.
- The market is expected to grow at a CAGR of 21.9% from 2024 to 2030.
- In terms of segment, pcr technology was the largest revenue generating technology in 2023.
- NGS Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 4,245.1 million |
| Market revenue in 2030 | USD 16,959.2 million |
| Growth rate | 21.9% (CAGR from 2023 to 2030) |
| Largest segment | Pcr technology |
| Fastest growing segment | NGS Technology |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 30.0% of the global synthetic biology market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 14,445.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe synthetic biology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.51% in 2023. Horizon Databook has segmented the Europe synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
With strong synthetic biology research, rising support from the government and private sector, the Europe synthetic biology market is expected to grow significantly during the forecast period. The organization is supporting Synthetic Biology Accelerator (IBISBA) project and Industrial Biotechnology Innovation.
This funding is expected to accelerate uptake of industrial biotechnology. Moreover, European Synthetic Biology Society brings together synthetic biologists from Europe and other regions. EUSynBioS supports synthetic biology researchers in Europe through industrial and academic collaborations.
It promoted Europe synthetic biology space through annual conferences and collection & distribution of current news on the field, creating a network of investigators, academics, &industry representatives. These factors are anticipated to drive market growth during the forecast period.
Reasons to subscribe to Europe synthetic biology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe synthetic biology market databook
-
Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe synthetic biology market , including forecasts for subscribers. This continent databook contains high-level insights into Europe synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe synthetic biology market size, by country, 2018-2030 (US$M)
Europe Synthetic Biology Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
